Literature DB >> 17651236

Biochemical and functional characterization of Salp20, an Ixodes scapularis tick salivary protein that inhibits the complement pathway.

K Tyson1, C Elkins, H Patterson, E Fikrig, A de Silva.   

Abstract

Ixodes ticks are vectors of several pathogens including Borrelia burgdorferi. Tick saliva contains numerous molecules that facilitate blood feeding without host immune recognition and rejection. We have expressed, purified, and characterized Ixodes scapularis salivary protein 20 (Salp20), a potential inhibitor of the alternative complement pathway that shares homology with the Isac protein family. When analysed by SDS-PAGE and size exclusion chromatography, Salp20 was approximately 48 kDa, more than double its predicted mass, primarily due N- and O-linked glycosylations. Recombinant Salp20 inhibited the alternative complement pathway by dissociating the C3 convertase, and partially protected a serum sensitive species of Borrelia from lysis by normal human serum. We propose that Salp20 facilitates tick feeding and possibly protects tick-borne pathogens from complement components.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17651236     DOI: 10.1111/j.1365-2583.2007.00742.x

Source DB:  PubMed          Journal:  Insect Mol Biol        ISSN: 0962-1075            Impact factor:   3.585


  49 in total

1.  Differential salivary gland transcript expression profile in Ixodes scapularis nymphs upon feeding or flavivirus infection.

Authors:  Kristin L McNally; Dana N Mitzel; Jennifer M Anderson; José M C Ribeiro; Jesus G Valenzuela; Timothy G Myers; Alvaro Godinez; James B Wolfinbarger; Sonja M Best; Marshall E Bloom
Journal:  Ticks Tick Borne Dis       Date:  2012-01-02       Impact factor: 3.744

2.  Inhibition of neutrophil function by two tick salivary proteins.

Authors:  Xiuyang Guo; Carmen J Booth; Michael A Paley; Xiaomei Wang; Kathleen DePonte; Erol Fikrig; Sukanya Narasimhan; Ruth R Montgomery
Journal:  Infect Immun       Date:  2009-03-30       Impact factor: 3.441

Review 3.  Mosquito Saliva Reshapes Alphavirus Infection and Immunopathogenesis.

Authors:  Siew-Wai Fong; R Manjunatha Kini; Lisa F P Ng
Journal:  J Virol       Date:  2018-05-29       Impact factor: 5.103

4.  Amblyomma americanum tick saliva insulin-like growth factor binding protein-related protein 1 binds insulin but not insulin-like growth factors.

Authors:  Ž M Radulović; L M Porter; T K Kim; M Bakshi; A Mulenga
Journal:  Insect Mol Biol       Date:  2015-06-25       Impact factor: 3.585

Review 5.  Borrelia burgdorferi and tick proteins supporting pathogen persistence in the vector.

Authors:  Faith Kung; Juan Anguita; Utpal Pal
Journal:  Future Microbiol       Date:  2013-01       Impact factor: 3.165

6.  Amblyomma americanum tick saliva serine protease inhibitor 6 is a cross-class inhibitor of serine proteases and papain-like cysteine proteases that delays plasma clotting and inhibits platelet aggregation.

Authors:  A Mulenga; T Kim; A M G Ibelli
Journal:  Insect Mol Biol       Date:  2013-03-24       Impact factor: 3.585

Review 7.  Reviewing molecular adaptations of Lyme borreliosis spirochetes in the context of reproductive fitness in natural transmission cycles.

Authors:  Jean I Tsao
Journal:  Vet Res       Date:  2009-04-16       Impact factor: 3.683

8.  Variability and action mechanism of a family of anticomplement proteins in Ixodes ricinus.

Authors:  Bernard Couvreur; Jérôme Beaufays; Cédric Charon; Kathia Lahaye; François Gensale; Valérie Denis; Benoît Charloteaux; Yves Decrem; Pierre-Paul Prévôt; Michel Brossard; Luc Vanhamme; Edmond Godfroid
Journal:  PLoS One       Date:  2008-01-02       Impact factor: 3.240

Review 9.  Subversion of complement by hematophagous parasites.

Authors:  Hélène Schroeder; Patrick J Skelly; Peter F Zipfel; Bertrand Losson; Alain Vanderplasschen
Journal:  Dev Comp Immunol       Date:  2009       Impact factor: 3.636

Review 10.  The pathogenesis of lyme neuroborreliosis: from infection to inflammation.

Authors:  Tobias A Rupprecht; Uwe Koedel; Volker Fingerle; Hans-Walter Pfister
Journal:  Mol Med       Date:  2008 Mar-Apr       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.